Synonyms: Bleph-10® | Klaron® | sulphacetamide
sulfacetamide is an approved drug (FDA (1945))
Compound class:
Synthetic organic
Comment: Sulfacetamide is a sulfonamide antibacterial compound that has been in clinical use since the 1940s [3]. It inhibits the bacterial dihydropteroate synthase pathway which generates the folic acid that is essential for bacterial growth.
|
|
No information available. |
Summary of Clinical Use ![]() |
Sulfacetamide sodium is authorised by the US FDA as an ophthalmic preparation to treat eye infections (Bleph-10®) and as a treatment for acne vulgaris (Klaron®), with generic formulations available. The compound was also available in combination with prednisolone sodium phosphate and with sulfathiazole + sulfabenzamide but these are now discontinued. The drug is not approved by the EMA, but individual European agencies have authorised its use. |
Mechanism Of Action and Pharmacodynamic Effects ![]() |
Sulfonamides are structural analogues of 4-aminobenzoic acid (pABA) an intermediate in the de novo synthesis of folate by some prokaryotes, lower eukaryotes and plants [2]. The antibacterial MMOA is competitive inhibition of bacterial dihydropteroate synthase (DHPS) resulting in a block of folate biosynthesis [1]. |
External links ![]() |
For extended ADME data see the following: Drugs.com |